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c Department of Surgery, Scarborough District Hospital, Scarborough YO12 6QL, United Kingdomh i g h l i g h t s Diversion colitis is a non-speciﬁc inﬂammation of a de-functioned segment of intestine after diversion of the faecal stream.
 Epidemiological studies are limited; in-spite of this an incidence rate of 100% has been shown in some studies.
 Up to 33% of patients with a stoma may have symptomatic diversion colitis.
 The absence of any characteristic pathognomonic features makes it difﬁcult to diagnose and appearances can be similar to IBD.
 Severely symptomatic patients will beneﬁt form re-anastamosis of the diverted faecal stream.a r t i c l e i n f o
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Introduction: Diversion colitis is a non-speciﬁc inﬂammation of a de-functioned segment of intestine
after diversion of the faecal stream. Aim: The aim of this study was to review the current level of
knowledge about diversion colitis. Methods: A literature search of relevant literature in the English
language was carried out on PUBMED, MEDLINE and EMBASE. The following keywords were used:
diversion colitis; disuse colitis; proctitis; colonic bacterial ﬂora; stoma; de-functioned colon; faecal
diversion; short chain fatty acids and lymphoid follicular hyperplasia. Results: In total 35 articles met the
inclusion criteria. 22 were case series, 9 were case reports, 2 were retrospective analysis and 2 were
prospective randomized controlled studies. Diversion colitis is invariably present in all diverted segments
of the colon. It is usually asymptomatic but can present with tenesmus, rectal discharge, bleeding per
rectum and abdominal pain. Major macroscopic changes include mucosal nodularity, erythema and
friability. Microscopic features are predominantly those of lymphoid follicular hyperplasia, apthous ul-
ceration and chronic inﬂammatory changes, mostly limited to sub mucosa. Treatment modalities include
surveillance for asymptomatic patients, restoration of bowel continuity for severely symptomatic cases
and the use of short chain fatty acid (SCFA) enemas in selected cases. Conclusion: The clinical presen-
tation of diversion colitis varies signiﬁcantly. In symptomatic patients short chain fatty acid enema may
help. Further prospective studies are required for evaluation.
© 2014 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Background
‘Diversion colitis’ is a relatively new term. It was ﬁrst mentioned
by Basil Morson and Dawson [1] in 1974 as a non-speciﬁc inﬂam-
mation limited to the mucosa in the de-functioned segment of the
colon. However, it was David Glotzer who coined the term ‘diver-
sion colitis’ after publishing a case series of 10 patients in 1981 [2].exham & Heatherwood, NHS
).
f of Surgical Associates Ltd.Since then this entity has been described in both retrospective and
prospective studies which have described the characteristic clinical,
endoscopic and histo-pathological ﬁndings. However till date the
precise pathogenesis of this condition remains unclear.
Diversion colitis is usually asymptomatic and therefore its
incidence may be under-estimated. Epidemiological studies are
limited; in-spite of this an incidence rate of 100% has been shown in
some studies with amanifestation time period of 4 weeks to 3 years
post index surgery [3]. Up to 33% of patients with a stoma may
present with symptoms of diversion colitis. These symptoms
include lower abdominal discomfort, pelvic pain, anorectal pain,
Table 1
PRISMA diagram for research strategy.
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fever [4,5].
The absence of any characteristic pathognomonic features, both
macroscopically and microscopically, makes it difﬁcult to differ-
entiate from active inﬂammatory bowel disease [6]. This presents a
diagnostic dilemma for clinicians, especially when it comes to de-
cision on re-anastomosis for patients who have diversion colitis
against a background of inﬂammatory bowel disease.
2. Methods
The systematic review was carried out with reference to the
validated AMSTAR (Assessment of Multiple Systematic Reviews)
measurement tool [7].
A literature search was performed using multiple electronic
search engines including PUBMED, MEDLINE and Cochrane Data-
base. The search was limited from January 1950 till January 2013.
The following keywords were used for the title/abstract search:
diversion colitis; stoma; SCFA; colonic bacterial ﬂora; defunctioned
colon; lymphoid follicular hyperplasia; disuse colitis and faecal
diversion. The keywords were used in mixed combinations to get
the greatest possible combination.
The “related articles” function was also used to identify addi-
tional studies. The reference sections of relevant articles were also
searched for, ﬁrst by title and subsequently by abstract review.
Combination, truncation and explode functions were used where
appropriate to give the search a good depth.
All published studies reporting diversion colitis were consid-
ered. No restriction on type of study was imposed. Data was
extracted on author, date of publication, study design and technical
aspects of the studies. Restrictions were made to include relevant
English language studies only.
The following outcomes were reviewed:
1. Demographics, type and indication of surgery, time from index
surgery, underlying pathology
2. Epidemiology, aetio-pathogenesis, clinical symptoms, endo-
scopic and microscopic ﬁnding of diversion colitis
3. Investigation modalities, complications and treatment options
relating to diversion colitis
Inclusion criteria:
1. All patients with surgical diversion of the faecal stream
2. Report on at least one of the outcome measures mentioned
above.
Exclusion criteria:
1. Study population based on children less than 19 years of age
2. Animal studies
3. The language used was not in English3. Results
The literature search revealed 3305 articles. The title and ab-
stract were reviewed by three independent researchers. This
resulted in 3224 articles being rejected as they did not meet the
criteria for inclusion. 81 articles were selected for further scrutiny.
PRISMA diagram (Table 1) illustrates the selection of articles for the
review.
In total 35 studies were included in the ﬁnal analysis; this
comprised two randomized trials, two retrospective studies,
twenty two case series and nine case reports.4. Incidence
Majority, if not all patients who have undergone diversion of the
faecal streammayeither havemacroscopic ormicroscopic evidence
of colitis [8e10]. This ranged from 91% in patients with pre-existing
inﬂammatory bowel disease [10,11] and 70%e74% in patients
without pre-existing inﬂammatory bowel disease [8,9]. More
recently a study from Poland described a 90% incidence of diversion
colitis on endoscopy in a series of 145 patients [5], this study sug-
gested that there was no signiﬁcant association between diversion
colitis and sex, age, type of stoma or mode of surgery performed.
Only one study has reported on the prevalence of diversion
colitis in asymptomatic patients with endoscopically normal mu-
cosa. This was a prospective study in 20 patients which reported a
prevalence of 100% [12].
5. Pathogenesis
Glotzer [2] in his report on 10 patients hypothesized that it
might be the result of bacterial overgrowth, presence of harmful
bacteria, nutritional deﬁciency, toxins or disturbance in the sym-
biotic relationship between luminal bacteria and themucosal layer;
however there was no data to support any of his hypotheses.
It has been reported that concentrations of carbohydrate fer-
menting anaerobic bacteria and pathogenic bacteria are reduced in
de-functioned colon [12,13]. This suggests that overgrowth of
anaerobic bacteria or a pathogenic bacterium is unlikely to be a
signiﬁcant aetiological factor.
However there is an increase in nitrate reducing bacteria in
patients with diversion colitis [14]. Nitrate reducing bacteria are
involved in the production of nitric oxide (NO). NO plays a pro-
tective role in low concentrations but at higher levels it becomes
toxic to the colonic tissue [45]. This increase in nitrate reducing
bacteriamay result in toxic levels of NO resulting in diversion colitis
but more studies are required to conﬁrm this hypothesis.
Recently ischaemia has been proposed as a cause of diversion
colitis [15]. Levels of Short Chain Fatty Acids (SCFA) in de-
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that shortage of SCFA may lead to an increase in arteriolar resis-
tance and present with features of ischaemia. This vasodilatory
effect of SCFAmay be a result of synthesis of Nitric Oxide (NO). SCFA
provide the exogenous substrate for NO productionwith the help of
micro ﬂora in the colon and NO has vasodilatory effect on the
vasculature [16]. However the exact role of NO is still being
investigated and to date no studies have been carried out to
elucidate the role of NO in the pathogenesis of diversion colitis.
Similarly, the role of the mucin layer in the pathogenesis of
diversion colitis has not been investigated fully. Sodium butyrate
instillation has been shown to increase colonic mucin synthesis. In
a single blind cross over trial, 8 patients had irrigation of the closed
rectal stump after Hartmann's procedure. In all patients there was
evidence of increased proliferation activity after SCFA irrigation
[17]. The mucous membrane has a protective role by forming a
barrier between the lumen and sub mucosa. This layer is thin and
abnormal in inﬂammatory conditions [18]. Based on this ﬁnding in
inﬂammatory bowel disease, it would be interesting to investigate
the relationship between the mucous layer and diversion colitis in
the out of stream colon.
Studies have indicated that bacterial metabolites such as buty-
rate may affect the host immune and inﬂammatory response.
However there have been conﬂicting results with trials with some
showing a good response in IBD patients [19], whereas others
showing no signiﬁcant effect [20]. However the role of immune
cells in the pathogenesis of diversion colitis in adults has not been
investigated and it may well be that there is an immune element to
diversion colitis.
6. Clinical symptoms
Majority of patients are asymptomatic [8], however up to 30%e
38% patients with a stoma may be suffering from symptomatic
diversion colitis [2,4,11,21]. In the presence of ulcerative colitis and
Crohn's disease the number of symptomatic patients rises to 87%
and 33% respectively [11].
These symptoms can start within 1 month to 3 years after the
index surgery [8,22].The most common symptoms include serous,
bloody or mucous discharge in 40% of the population, tenesmus
and abdominal pain in 15% of the population [5]. There have been
reports of severe rectal bleeding [22,23]. There is a case report of
diversion colitis causing severe sepsis necessitating a colectomy
[24] and a report of massive rectal distension causing bilateral
ureteric obstruction [25]. However, in a prospectively performed
study the incidence of signiﬁcant symptoms was 6% with only 1
patient requiring a blood transfusion [22]. This could be due to the
fact that the authors did not consider small amounts of mucous
discharge as a signiﬁcant symptom in contrast to previous studies.
A second factor could be the time lapse between index surgery and
examination. Themean time in previous studies was approximately
4 years, while Whelan [22] examined his patients at 10 months,
therefore potentially causing a bias in his ﬁndings.
The symptoms resolve once bowel continuity is restored in
almost all studies [21,26,27]. One study put the duration of return to
normal architecture as 3 months [10]. Symptoms such as con-
stipation, intestinal colic, abdominal distension and vague
dyspepsia that remain after reconstitution of bowel continuity;
were thought to arise secondary to changes in muscular layers and
motility of muscularis propria as a result of diversion colitis [28].
Vincenzo [29] tested this hypothesis by measuring smooth muscle
thickness andmotility in the defunctioned colonic segment and the
proximal in-stream colonic segment and did not ﬁnd any signiﬁ-
cant difference between the two segments. It may well be that no
signiﬁcant difference in this study was found because of the shortduration of the study carried out, and signiﬁcant differences may
have become evident with increasing duration of diversion.
7. Investigations
Diversion colitis is diagnosed on clinical history, symptoms,
endoscopic and histological ﬁndings. The most characteristic
radiological ﬁnding on double-contrast barium enema (DCBE) is a
variable distribution of lymphoid follicular hyperplasia (LFH) in 38%
of the population in a study [30]. This is in contrast to ﬁndings by
Glotzer [2] who documented LFH in 13% of his study population.
This discrepancy may be explained by the increased sensitivity of
DCBE in detecting LFH. This paper however did not investigate the
association between LFH and severity of diversion colitis.
LFH may also be present in IBD, colonic carcinoma and lym-
phoma [31]. This adds further to the difﬁculty already posed to
clinicians in diagnosing diversion colitis.
8. Macroscopic ﬁndings
The macroscopic changes in diversion colitis may involve the
whole de-functioned colon or segments only. These ﬁndings
include diffuse granularity, mucous plugs, erythema, blurring of
vascular pattern in approximately 90% of the population. It is also
associated with mucosal friability (80%) oedema (60%), apthous
ulceration and bleeding to varying degrees
[2,5,15,20,21,27,32e34,43]. There is a case report of diversion colitis
causing mucosal tears at endoscopy [35].
The defunctioned colon is associated with a 35% reduction in
rectal volume at 1 month [21] however there is no associated
change in the physiological parameters of the defunctioned
segment of the bowel such as atrophic changes in the muscularis
propria [28] or alteration in the intestinal motility [29], therefore it
is unlikely to be a contributory factor in the pathogenesis of
diversion colitis.
9. Microscopic ﬁndings
Microscopic ﬁndings are inconsistent. Crypt branching, atrophy,
crypt distortion, mucin depletion, regenerative hyperplasia, paneth
cell metaplasia, thickening of muscularis mucosa, diffuse active
mucosal inﬂammation with crypt abscess, ulceration, vacuolar and
epithelial degeneration along with features of chronic inﬂamma-
tion usually conﬁned to mucosa are seen with varying degree of
severity [21,27,29,31,33,43].
The most striking feature often seen in diversion colitis is
lymphoid follicular hyperplasia [21,31]. More recently features of
ischaemia such as ﬁbrosis and superﬁcial coagulative necrosis have
been described [15]. These features are non-speciﬁc however and
to date no pathognomonic feature of diversion colitis has been
identiﬁed in any of the studies.
Histological features of diversion colitis resemble those of
Crohn's disease except for the absence of Crohn's Rosary in diver-
sion colitis. Crohn's rosary is a linear collection of lymphoid
aggregate on the outer border of muscularis propria and connective
tissue. This distinction is important as a wrong diagnosis of Crohn's
would lead to wrong treatment or delay in re-anastomosis [10,36].
10. Treatment
The symptoms of Diversion Colitis were successfully treated
with 60 ml irrigation of the diverted colon with short chain fatty
acid enemas twice a day for 4e6 week [13]. Similar results were
produced in four patients with diversion colitis, when they were
prescribed SCFA irrigation [27].
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caution as the numbers involved were small and a similar study
could not replicate the same ﬁndings in a double blind placebo
controlled trail [37]. In this study the same protocol was followed as
Harig [13] except for the duration of the study and the concentra-
tion of the irrigation solution. The discrepancy in results may be
explained by the reduced concentration of SCFA enema used or by
the shorter duration of therapy to which the trial patients were
exposed to i.e. 2 weeks only as compared to 6 weeks of therapy by
Harig.
Resolution of diversion colitis based on endoscopic and histo-
logic examination has been reported with irrigation of the diverted
segment of the colonwith ﬁbre [38,46], 5-ASA and steroid enema to
varying effect [39e41,44].
Where feasible, treatment of diversion colitis should be pri-
marily directed at restoring colonic continuity to restore the
luminal ﬂow. This will resolve the symptoms and allow the affected
bowel to return to normal. Re-anastomosis has proven to be
consistently effective in halting the symptoms of colitis in a number
of studies [2,10,27,32].
Based on a study of 145 patients, Szczepkowski [5] proposed a
management strategy for patients with de-functioned distal stoma.
He divided patients with faecal diversion into three groups:
 Group 1: No clinical, morphological or endoscopic evidence of
diversion colitis
 Group 2: Mild or moderate signs of diversion colitis
 Group 3: Severe diversion colitis
Group 1 can be treated conservatively; group 2 can have a trial
of conservative management prior to restoration of bowel conti-
nuity and 3 should ideally undergo restoration of bowel continuity.
If surgical option is not feasible or available then other treatment
options should be tried to resolve the inﬂammation.
Re-anastomosis of diverted segments in patients with pre-
existing inﬂammatory bowel disease is a more difﬁcult decision
because inﬂammation in the diverted segment could represent
inﬂammatory bowel disease or diversion colitis with dictating
different courses of action [3,5,10].11. Future research
Further research is required into whether diversion colitis is
associated with cancer risk and to establish the need for surveil-
lance of the distal diverted stump for pathology.
Similarly the role of the mucin layer in the pathogenesis of
diversion colitis and its relationship to butyrate instillation has not
been investigated adequately. It would be interesting to see if there
is a relationship between the mucous layer of the colon and
diversion colitis.
The presence of inﬂammation is associated with reduced
oxidation of SCFA. Also in inﬂammatory conditions like UC there are
increased levels of sulphides. Hydrogen sulphide interacts with co-
enzyme A inhibiting SCFA dehydrogenase which in turn stops
ketogenesis of butyrate. This prevents butyrate being used by the
colonocytes [42]. TNF-alpha reduces oxidation of SCFA in inﬂamed
mucosa this may explain the effectiveness of anti-TNF medications
in inﬂammatory conditions. Though these ﬁndings have been
shown in an inconsistent fashion in patients with inﬂammatory
bowel disease, no studies have been carried out to our knowledge
in diversion colitis.
The role of butyrate metabolism, Nitrous Oxide and the effect of
nitrous oxide synthase inhibition on diversion colitis once inves-
tigated may lead to newer treatment options.Dose response studies on SCFA irrigation are lacking and not
robust, such studies may lead to improvement in results.
12. Conclusion
The result of this review suggests that diversion colitis is
underreported. The aetiology remains unclear. The evidence that it
is a consequence of SFA deﬁciency is tenuous. Features which help
in distinction from IBD include absence of crypt abscesses and LFH,
though these can be non-speciﬁc.
In view of the fact that symptoms related to diversion are low,
the term diversion syndrome should be used for asymptomatic
patients, whereas the term diversion colitis is used for symptomatic
patients.
The ideal management where the diagnosis is conﬁrmed is
restoration of bowel continuity. A theoretical case could be made
for trialling a period of enteroclysis to assess therapeutic response
[41].
13. Limitations
This review does have its limitations. Firstly there are relatively
few published trials, mostly observational non blinded studies and
therefore inappropriate to draw ﬁrm conclusions. The major limi-
tation to this study is the fact that it is a review of primarily
observational, non-comparative studies and case reports, some of
which were retrospective in nature. Similarly not all the papers
reported on the entire desired outcome measures, meaning that
some results are based on the results of a few studies. Even with
these limitations there is undoubtedly a risk of morbidity associ-
ated with diversion. The presence of diversion may have implica-
tions on the quality of life. 67% of stomas are never reversed and
there is a risk of diversion colitis. The results of this review indicate
that care should be taken to ensure diversion colitis is adequately
diagnosed and treated in the out of stream segment of the colon.
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